Showing 37,021 - 37,040 results of 72,182 for search '(( 01 ((0 decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.29s Refine Results
  1. 37021
  2. 37022
  3. 37023
  4. 37024
  5. 37025
  6. 37026
  7. 37027

    Water balance components. by Juul Limpens (535589)

    Published 2014
    “…Different letters denote statistically significant differences between tree density treatments for the same year based on 2-way ANOVAs with treatment as factor and block as random factor. Ns = P<0.10, (*) = 0.10≥P<0.05, * = P≤0.05, ** = 0.05>P≤0.01, *** = P<0.01.…”
  8. 37028

    Efficacy of SCIG in PAD and SAD patients. by Francesco Cinetto (8638674)

    Published 2021
    “…<p>Following SCIG initiation there were a statistic significant decrease in the annual infectious rate in both patients with PAD (panel A) and SAD (panel B). …”
  9. 37029
  10. 37030

    Pretreatment of PDTC and DEX in rats attenuated LPS-induced cognitive impairment and elevation of TNF-α and IL-6. by Xiaobao Zhang (3498446)

    Published 2018
    “…Combined treatment with PDTC and DEX decreased LPS-induced TNF-α and IL-6 expression. (Mean ± SEM; **P < 0.01 compared with corresponding control group; #P < 0.05; ##P < 0.01 compared with LPS group).…”
  11. 37031

    Average firing-rate changes during the nicotine dose-response session. by Karine Guillem (204138)

    Published 2011
    “…<p>(<b>A</b>) Average prevalence of neurons (average number of neurons per subject) that showed either a decrease or an increase in average firing during nicotine SA is plotted as a function of nicotine dose. …”
  12. 37032

    Image1_Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data.JPEG by Athanasios Chamzas (19699780)

    Published 2024
    “…Model based simulations indicated the best initial dose for the Hispanic population is 0.1 mg/kg/day. The proposed titration strategy, with three dose adjustments based on trough levels of tacrolimus, increased the proportion of patients within the target range (10–12 ng/mL) more than 2.5-fold and decreased the proportion of patients outside the therapeutic window by 50% after the first week of treatment.…”
  13. 37033

    Table2_Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data.DOCX by Athanasios Chamzas (19699780)

    Published 2024
    “…Model based simulations indicated the best initial dose for the Hispanic population is 0.1 mg/kg/day. The proposed titration strategy, with three dose adjustments based on trough levels of tacrolimus, increased the proportion of patients within the target range (10–12 ng/mL) more than 2.5-fold and decreased the proportion of patients outside the therapeutic window by 50% after the first week of treatment.…”
  14. 37034

    Table1_Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data.DOCX by Athanasios Chamzas (19699780)

    Published 2024
    “…Model based simulations indicated the best initial dose for the Hispanic population is 0.1 mg/kg/day. The proposed titration strategy, with three dose adjustments based on trough levels of tacrolimus, increased the proportion of patients within the target range (10–12 ng/mL) more than 2.5-fold and decreased the proportion of patients outside the therapeutic window by 50% after the first week of treatment.…”
  15. 37035

    Image2_Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data.JPEG by Athanasios Chamzas (19699780)

    Published 2024
    “…Model based simulations indicated the best initial dose for the Hispanic population is 0.1 mg/kg/day. The proposed titration strategy, with three dose adjustments based on trough levels of tacrolimus, increased the proportion of patients within the target range (10–12 ng/mL) more than 2.5-fold and decreased the proportion of patients outside the therapeutic window by 50% after the first week of treatment.…”
  16. 37036
  17. 37037
  18. 37038
  19. 37039

    The effect of NAT administration on motor and sensory function following SCI. by Anna Victoria Leonard (568218)

    Published 2014
    “…Whilst NAT treated animals demonstrated earlier increases in movement frequency, no significant difference was observed between groups. A similar significant decrease in sensory function was observed in both the left (C) and right (D) hindlimbs of both treatment groups. ** denotes p<0.01, *** denotes p<0.001 when compared to sham. # denotes p<0.05 compared to vehicle.…”
  20. 37040